HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histopathological evaluation of griseofulvin therapy in lichen planus. A double-blind controlled study.

Abstract
In a double-blind trial on 44 patients having lichen planus, 500 mg griseofulvin-FP daily for 8 weeks produced significantly better results compared to a placebo. The clinical improvement was accompanied by corresponding histological changes.
AuthorsV N Sehgal, R Bikhchandani, R V Koranne, M Nayar, H M Saxena
JournalDermatologica (Dermatologica) Vol. 161 Issue 1 Pg. 22-7 ( 1980) ISSN: 0011-9075 [Print] Switzerland
PMID6995186 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Griseofulvin
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Griseofulvin (therapeutic use)
  • Humans
  • Lichen Planus (drug therapy, pathology)
  • Male
  • Middle Aged
  • Skin (pathology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: